Identification of potential microRNA panels for pancreatic cancer diagnosis using microarray datasets and bioinformatics methods
暂无分享,去创建一个
[1] Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.
[2] L. Wang,et al. MiRNA-8073 targets ZnT1 to inhibit malignant progression of ovarian cancer. , 2019, European review for medical and pharmacological sciences.
[3] H. Krmac,et al. A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients , 2019, Scientific Reports.
[4] H. Kocher,et al. Pancreatic Cancer , 2019, Methods in Molecular Biology.
[5] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[6] H. Sudo,et al. Abstract 510: MicroRNA-8073 as a tumor suppressor and a potential diagnostic and therapeutic target , 2018, Molecular and Cellular Biology / Genetics.
[7] Anqi Song,et al. Breast cancer identification via modeling of peripherally circulating miRNAs , 2018, PeerJ.
[8] Igor Jurisica,et al. mirDIP 4.1—integrative database of human microRNA target predictions , 2017, Nucleic Acids Res..
[9] M. Omrani,et al. A bioinformatics approach for identification of miR-100 targets implicated in breast cancer. , 2017, Cellular and molecular biology.
[10] M. Makary,et al. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers , 2017, Proceedings of the National Academy of Sciences.
[11] R. Postier,et al. Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer , 2017, Oncotarget.
[12] Bin Zhou,et al. Early detection of pancreatic cancer: Where are we now and where are we going? , 2017, International journal of cancer.
[13] Xiaoyi Huang,et al. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer , 2017, Scientific Reports.
[14] J. Farrell. Pancreatic Cysts and Guidelines , 2017, Digestive Diseases and Sciences.
[15] Tao Zhang,et al. MicroRNA-4530 promotes angiogenesis by targeting VASH1 in breast carcinoma cells , 2017, Oncology letters.
[16] A. Goel,et al. Emerging Role of MicroRNAs as Liquid Biopsy Biomarkers in Gastrointestinal Cancers , 2017, Clinical Cancer Research.
[17] M. Krstic-Demonacos,et al. miR-663a regulates growth of colon cancer cells, after administration of antimicrobial peptides, by targeting CXCR4-p21 pathway , 2017, BMC Cancer.
[18] R. Wolff,et al. Association of cigarette smoking and microRNA expression in rectal cancer: Insight into tumor phenotype. , 2016, Cancer epidemiology.
[19] Muhammad Yasir,et al. microRNA analysis of gastric cancer patients from Saudi Arabian population , 2016, BMC Genomics.
[20] P. He,et al. MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD , 2016, BMC Cancer.
[21] Paula Ribeiro,et al. miRNet - dissecting miRNA-target interactions and functional associations through network-based visual analysis , 2016, Nucleic Acids Res..
[22] T. Ohtsuka,et al. Overexpression of microRNA-5100 decreases the aggressive phenotype of pancreatic cancer cells by targeting PODXL. , 2016, International journal of oncology.
[23] H. An,et al. Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer. , 2016, Lung cancer.
[24] Neveen Abd El Moneim Hussein,et al. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer , 2016, Journal of Cancer Research and Clinical Oncology.
[25] S. Aggarwal,et al. Systematic Review Of Burden Of Pancreatic Cancer. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[26] C. Boland,et al. Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia , 2015, Clinical Cancer Research.
[27] Hongzhuan Yin,et al. Sp1-driven up-regulation of miR-19a decreases RHOB and promotes pancreatic cancer , 2015, Oncotarget.
[28] A. Carrato,et al. A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs , 2015, Journal of Gastrointestinal Cancer.
[29] Motohiro Kojima,et al. MicroRNA Markers for the Diagnosis of Pancreatic and Biliary-Tract Cancers , 2015, PloS one.
[30] Zhihua Liu,et al. MiRNA-1469 promotes lung cancer cells apoptosis through targeting STAT5a. , 2015, American journal of cancer research.
[31] Tao Wang,et al. Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer. , 2015, European urology.
[32] Bin Wu,et al. Salivary microRNAs Show Potential as a Noninvasive Biomarker for Detecting Resectable Pancreatic Cancer , 2014, Cancer Prevention Research.
[33] Heng-jun Gao,et al. Aberrant expression of microRNAs in serum may identify individuals with pancreatic cancer. , 2014, International journal of clinical and experimental medicine.
[34] G. A. Ganepola,et al. Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer. , 2014, World journal of gastrointestinal oncology.
[35] S. Bojesen,et al. MicroRNA biomarkers in whole blood for detection of pancreatic cancer. , 2013, JAMA.
[36] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[37] J. Wang,et al. Identification of microRNAs associated with lymphangiogenesis in human gastric cancer , 2014, Clinical and Translational Oncology.
[38] H. Matsubara,et al. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma , 2013, British Journal of Cancer.
[39] Sean R. Davis,et al. NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..
[40] S. Knudsen,et al. Cell-Free Plasma MicroRNA in Pancreatic Ductal Adenocarcinoma and Disease Controls , 2012, Pancreas.
[41] Paul Fockens,et al. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer , 2012, Gut.
[42] Y. Gong,et al. Combination of plasma microRNAs with serum CA19‐9 for early detection of pancreatic cancer , 2012, International journal of cancer.
[43] Tommaso Mazza,et al. Mirna Expression Profiles Identify Drivers in Colorectal and Pancreatic Cancers , 2012, PloS one.
[44] M. Saif,et al. Early detection of pancreatic cancer. , 2012, JOP : Journal of the pancreas.
[45] J. Copland,et al. RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer. , 2012, Gynecologic oncology.
[46] Yi Zheng,et al. A distinct role of RhoB in gastric cancer suppression , 2011, International journal of cancer.
[47] Trey Ideker,et al. Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..
[48] A. Jemal,et al. Global Cancer Statistics , 2011 .
[49] Yeon-Soo Seo,et al. RhoB induces apoptosis via direct interaction with TNFAIP1 in HeLa cells , 2009, International journal of cancer.
[50] C. Croce,et al. MicroRNAs in cancer: small molecules with a huge impact. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] Markus Müller,et al. Bioinformatics for protein biomarker panel classification: what is needed to bring biomarker panels into in vitro diagnostics? , 2009, Expert review of proteomics.
[52] J. Barkin,et al. Should Patients With a Strong Family History of Pancreatic Cancer Be Screened on a Periodic Basis for Cancer of the Pancreas? , 2009, Pancreas.
[53] D. Radisky,et al. Reactivation of suppressed RhoB is a critical step for the inhibition of anaplastic thyroid cancer growth. , 2009, Cancer research.
[54] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[55] Helen Hickey,et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. , 2004, The New England journal of medicine.
[56] Gary D. Bader,et al. An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.
[57] Sudhir Srivastava,et al. Markers for early detection of cancer: Statistical guidelines for nested case-control studies , 2002, BMC medical research methodology.
[58] C. Moskaluk,et al. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. , 1997, Cancer research.
[59] W. Birchmeier,et al. Molecular mechanisms leading to loss of differentiation and gain of invasiveness in epithelial cells , 1993, Journal of Cell Science.
[60] W. Birchmeier,et al. Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas. , 1993, Seminars in cancer biology.